当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析

亚虹医药-U

(688176)

  

流通市值:24.59亿  总市值:37.73亿
流通股本:3.71亿   总股本:5.70亿

亚虹医药-U(688176)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.83亿元,每股收益-0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益230024.17万元,未分配利润-112755.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产255805.25万元,负债25781.08万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入24,319,537.4513,753,343.122,996,071.2577,772.96
营业总成本117,128,087.84447,147,582.54296,713,781.81206,880,387.42
营业利润-83,313,061.22-404,003,134.48-267,129,827.43-185,906,801.46
利润总额-83,313,061.22-401,503,000.65-268,156,193.61-185,433,139.74
净利润-82,969,385.29-400,834,988.69-268,156,193.61-185,433,139.74
其他综合收益-1,115,257.612,100,690.641,363,641.291,958,305.92
综合收益总额-84,084,642.9-398,734,298.05-266,792,552.32-183,474,833.82
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,305,728,450.842,375,453,052.652,432,547,471.242,506,434,676.39
非流动资产合计252,324,084.87256,817,414.55260,837,030.53191,485,318.68
资产总计2,558,052,535.712,632,270,467.22,693,384,501.772,697,919,995.07
流动负债合计203,168,340.65185,347,147.06115,181,905.784,997,964.48
非流动负债合计54,642,466.457,154,588.0560,051,844.2517,102,075.97
负债合计257,810,807.05242,501,735.11175,233,749.95102,100,040.45
归属于母公司股东权益合计2,298,581,382.992,387,969,481.662,516,292,880.642,595,819,954.62
股东权益合计2,300,241,728.662,389,768,732.092,518,150,751.822,595,819,954.62
负债和股东权益合计2,558,052,535.712,632,270,467.22,693,384,501.772,697,919,995.07
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计26,465,560.0135,385,493.4226,713,645.035,887,060.96
经营活动现金流出小计155,575,595.09433,572,182.24310,936,123.57206,548,645.64
经营活动产生的现金流量净额-129,110,035.08-398,186,688.82-284,222,478.54-200,661,584.68
投资活动现金流入小计1,104,473,904.731,959,342,525.592,203,847,556.141,521,441,132.81
投资活动现金流出小计550,057,471.222,326,147,021.412,483,534,985.111,253,656,848.11
投资活动产生的现金流量净额554,416,433.51-366,804,495.82-279,687,428.97267,784,284.7
筹资活动现金流入小计36,500,00073,787,767.633,800,000-
筹资活动现金流出小计12,678,974.6811,776,703.967,791,529.435,276,489.3
筹资活动产生的现金流量净额23,821,025.3262,011,063.6426,008,470.57-5,276,489.3
汇率变动对现金及现金等价物的影响-1,256,726.15764,588.81242,567.281,676,466.23
现金及现金等价物净增加额447,870,697.6-702,215,532.19-537,658,869.6663,522,676.95
期末现金及现金等价物余额775,167,766.25327,297,068.65491,853,731.181,093,035,277.79
最新报告期:2024-04-19
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西南证券杜向阳,汤泰萌-0.46-0.440.002024-04-19
太平洋周豫,霍亮-0.73-0.68--2024-02-05
TOP↑